ER

Merit Medical to acquire Thomas Medical for $167M

Wednesday, November 28, 2012 10:19 AM

Merit Medical Systems, a manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, has entered into a stock purchase agreement to acquire Thomas Medical Products from GE Healthcare in a $167 million all-cash transaction, subject to customary post-closing adjustments.

More... »

NEOMED Institute aims to renew biopharmaceutical research in Québec

Tuesday, November 27, 2012 11:33 AM

AstraZeneca Canada and Pfizer Canada are forming a partnership with the Québec government to create the NEOMED Institute, a new kind of life sciences research center. A total of $100 million will be invested to establish and support the research center over five years.

More... »

TauRx receives $111.8M from Genting for Alzheimer's trials

Tuesday, November 20, 2012 02:02 PM

TauRx Pharmaceuticals of Singapore has received a further equity investment of $31.5 million from Genting Management (GMS), a Singapore-based subsidiary of Genting Berhad.

More... »

Chiromics, BMS form drug discovery alliance

Tuesday, November 20, 2012 09:39 AM

Chiromics, a drug discovery company based in Princeton, N.J., has formed a strategic research alliance with global biopharmaceutical company Bristol-Myers Squibb.

More... »

CFFT, Pfizer expand collaboration on cystic fibrosis by $58M

Monday, November 19, 2012 02:46 PM

Cystic Fibrosis Foundation Therapeutics (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, has expanded its research collaboration with Pfizer designed to discover new drugs to treat people with the most common mutation of cystic fibrosis (CF), Delta F508.

More... »

Wright Medical, BioMimetic to combine businesses

Monday, November 19, 2012 02:17 PM

Wright Medical Group, a global orthopedic medical device company, and BioMimetic Therapeutics, a biotech specializing in products to promote the healing of musculoskeletal injuries and diseases, have entered into a definitive agreement for a business combination of the Tennessee-based companies.

More... »

Factor Bioscience awarded two NIH grants for Alzheimer's research

Monday, November 19, 2012 11:12 AM

The National Institutes of Health, through the National Center for Advancing Translational Sciences, has awarded Factor Bioscience, a developer of cell-based therapeutics and research tools, two Small Business Innovation Research (SBIR) grants to accelerate the development of new treatments for Alzheimer's disease.

More... »

Chimerix appoints Michelle Berrey as CMO

Monday, November 19, 2012 10:45 AM

Chimerix, a Durham, N.C.-based biotechnology company developing orally-available antiviral therapeutics, has appointed Michelle Berrey, MD, MPH, as chief medical officer.

More... »

Janssen R&D establishes global cross-pharma clinical trial Investigator Databank

Monday, November 19, 2012 10:18 AM

Janssen Research & Development, based in Raritan, N.J., has established a global cross-pharmaceutical Investigator Databank designed to improve efficiencies of industry-sponsored clinical trials. Merck and Eli Lilly are the first two companies to join Janssen in this effort.

More... »

Allergan to acquire SkinMedica for $350M

Monday, November 19, 2012 09:22 AM

Allergan, a multi-specialty health care company, has entered into a definitive agreement to acquire SkinMedica, a privately held,  topical aesthetics skin care business.

More... »